Change the trajectory before it changes you.

What prediabetes actually means

Prediabetes is the middle zone. Your blood sugar is higher than normal but not quite high enough to meet the threshold for type 2 diabetes. Most people feel completely fine. That is what makes it so common and so dangerous.

The standard diagnosis thresholds used by the American Diabetes Association are a fasting glucose between 100 and 125 mg/dL, an HbA1c between 5.7 and 6.4 percent, or a 2-hour glucose between 140 and 199 mg/dL on an oral glucose tolerance test. Hit any of those and you meet criteria for prediabetes.

The good news most people never hear

Prediabetes is often reversible. Not always. Not for everyone. But the trajectory can be changed with a real plan, especially when it is caught early. Research on the Diabetes Prevention Program showed that modest weight loss and lifestyle change reduced the risk of progression to type 2 diabetes significantly in participants who followed the program.

The honest version: the plan works when people do it. Many people cannot do it alone. This is where medication can be part of the conversation.

Why weight loss is the main lever

Prediabetes is driven largely by insulin resistance. Insulin resistance is worsened by excess body fat, particularly visceral fat around the organs. Reducing body fat, especially visceral fat, often improves insulin sensitivity measurably. This is why weight loss is the first-line recommendation for most people with prediabetes.

Research on the Diabetes Prevention Program suggested that participants who lost around 5 to 7 percent of their body weight through lifestyle change reduced their risk of progressing to type 2 diabetes. A 180 pound person losing 10 to 13 pounds and keeping it off is a meaningful change to the trajectory.

Where GLP-1 medications fit in

GLP-1 medications are a class of drugs that mimic a natural gut hormone. Brand-name products include Wegovy (semaglutide) and Zepbound (tirzepatide), which are FDA-approved for chronic weight management in certain adults. They are also approved for type 2 diabetes under different brand names (Ozempic, Mounjaro).

GLP-1 is not FDA-approved specifically for prediabetes as a standalone indication. That said, many patients with prediabetes meet the approved criteria for chronic weight management (BMI thresholds plus weight-related health conditions). Some also meet criteria for diabetes care if their labs move. A licensed provider decides based on your specific situation.

Compounded versions of semaglutide and tirzepatide are custom-prepared by licensed compounding pharmacies. They are not FDA-approved for any indication.

How GLP-1 changes the metabolic picture

1. 1Reduces appetite. Acts on hunger centers in the brain. Many patients describe a quieter relationship with food after a few weeks.
2. 2Slows gastric emptying. Meals linger longer in the stomach. Post-meal glucose spikes flatten out. Insulin release is more controlled.
3. 3Supports insulin signaling. GLP-1 helps the pancreas release insulin in response to meals and reduces glucagon, the hormone that raises blood sugar from stored liver glycogen.
4. 4Can improve metabolic markers. Trials of brand-name products have reported improvements in HbA1c, weight, and other metabolic markers in patients who took the medications as prescribed.

What the research shows

The evidence base for GLP-1 medications in metabolic disease is large. Some key points from peer-reviewed research on brand-name FDA-approved products:

• STEP trials. Brand-name semaglutide produced average body weight reductions of roughly 15 to 17 percent over 68 weeks in adults with obesity or overweight plus a weight-related condition.
• SURMOUNT trials. Brand-name tirzepatide produced average reductions of up to 22.5 percent at the highest dose over 72 weeks in adults with obesity.
• Diabetes prevention. Research on GLP-1 medications in adults with prediabetes and obesity has reported reductions in the rate of progression to type 2 diabetes in some trials.
• HbA1c improvements. Clinical studies in adults with type 2 diabetes have reported HbA1c reductions in participants taking brand-name GLP-1 receptor agonists.

These results describe specific brand products. Compounded versions have not been studied the same way. Individual results vary widely.

A real prediabetes plan

Medication is one part. The full plan includes:

Nutrition for blood sugar stability

Prioritize protein and fiber. Reduce refined carbohydrates and added sugars. A Mediterranean-style approach has strong research support. The goal is not starvation. It is steadier blood glucose across the day.

Movement that matters

Strength training builds muscle, which is the largest glucose-absorbing tissue in the body. Walking after meals blunts glucose spikes measurably. Aerobic exercise improves insulin sensitivity. All three belong in the plan. Start where you are and build up.

Sleep, because it drives metabolism

Seven to nine hours. Consistent timing. Cool dark room. Sleep is the most under-appreciated metabolic intervention. One bad night measurably worsens insulin sensitivity the next day.

Lab monitoring

Re-check HbA1c and fasting glucose every 3 to 6 months. Add fasting insulin and HOMA-IR for a more complete picture of insulin sensitivity. Labs tell you whether the plan is working, not how hard it feels.

Community or accountability

The Diabetes Prevention Program works in part because participants meet with a coach regularly. Habit change is hard alone. Find a provider who checks in, a coach, a group program, or even a friend on the same path. Accountability matters.

Who may not be a candidate for GLP-1

• Personal or family history of medullary thyroid carcinoma or MEN2.
• Personal history of pancreatitis.
• Pregnancy or breastfeeding.
• Active or recent cancer.
• Severe gastroparesis or significant gastrointestinal disease.
• Active eating disorder.
• Certain medication interactions.
• BMI or clinical profile that does not meet the provider's prescribing criteria.

If a Puri-affiliated provider declines, they will explain why and you will not be charged for medication. Prediabetes is reversible for many people without medication, so a decline is not the end of the conversation.

How to think about the decision

• Get labs first. Know your baseline HbA1c, fasting insulin, and fasting glucose.
• Start the foundation work. Protein, fiber, strength training, walking, sleep. These work with or without medication.
• Talk to a provider about GLP-1. Your specific labs and goals matter more than any general article.
• Track labs, not just the scale. HbA1c in 3 months tells you what is really changing.

When you are ready, start your assessment. A licensed physician reviews intakes within about 24 hours.